• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Xetra	100,000	04.10.24 10:17:13	-0,600	-0,60%	99,800	100,000	99,900	100,600
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	92,500	04.10.24 08:47:22	+2,000	+2,21%	92,500	93,500	92,500	90,500